Cytek Biosciences, Inc.CTKBNASDAQ
Loading
Cash & Equivalents Over TimeContracting
Percentile Rank17
3Y CAGR-32.6%
5Y CAGR-11.3%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
-32.6%/yr
Annual compound
5Y CAGR
-11.3%/yr
Recent deceleration
Percentile
P17
Within normal range
vs 5Y Ago
0.5x
Contraction
Streak
4 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $90.85M | -8.0% |
| 2024 | $98.72M | -41.0% |
| 2023 | $167.30M | -43.6% |
| 2022 | $296.60M | -18.7% |
| 2021 | $364.62M | +120.7% |
| 2020 | $165.23M | +448.5% |
| 2019 | $30.12M | - |